Innate Pharma

Become the referent of this startup

Innate Pharma develops Lumoxiti is a first-in class specialty oncology product for hairy cell leukemia (HCL) and other monoclonal antibodies for cancer treatments.
Automatic translation

Technologies

  • REDBIOTECH
  • BIOENGINEERING

Activity area

  • PHARMATECH
  • CLINIC
  • ONCOLOGY
  • RESEARCH
  • BIOTECH
  • IMMUNOLOGY

Maturity stage

  • Mature

Contact

http://www.innate-pharma.com

Key information

Year of creation

1999

Workforce

51 - 500

Maturity stage

Mature

Total fundraising amount

24 500 000 €

Last round table level

Contact information

info@remove-this.innate-pharma.com

Investment

Total fundraising amount

24 500 000 €

Maximum round table reached

Date Amount Investors Round table
01/04/2000 4 500 000,00 €
01/08/2002 20 000 000,00 €

Similar start-ups